• BioDelivery Sciences International Inc., of Raleigh, N.C., received a milestone payment of $2.5 million from Meda AB, of Goteborg, Sweden, for registration and pricing approval of Breakyl (Onsolis). It will be eligible for a final milestone payment of $2.5 million upon commercial launch, which is anticipated in late 2012.